Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/25 16:19 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Bergstrom Donald A | MA | O | P,R,D | 11 | S.m | -482 | 5.00 | 0 | -96 | 616 | D | |||||||||||||||
3/31/25 16:15 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Rahmer Peter | MA | O | See rema | 13 | S.m | -1,491 | 5.83 | 0 | -256 | 515 | D | |||||||||||||||
3/31/25 16:13 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Catinazzo Thomas | MA | O | CFO | 11 | S.m | -594 | 5.46 | 0 | -109 | 379 | D | |||||||||||||||
3/31/25 16:12 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Adams Brian | MA | O | GC | 11 | S.m | -313 | 4.97 | 0 | -63 | 406 | D | |||||||||||||||
2/13/25 20:56 | 2/11/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Patel Sanjiv | MA | DO | P,CEO | 4 | S.dm | -3,872 | 4.98 | 0 | -777 | 2,128 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |